• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ENDOTAK RELIANCE SG; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ENDOTAK RELIANCE SG; IMPLANTABLE LEAD Back to Search Results
Model Number 0293
Device Problems Signal Artifact/Noise (1036); Over-Sensing (1438); Pacing Problem (1439); Low impedance (2285); Defective Device (2588)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/16/2024
Event Type  Injury  
Event Description
It was reported that this right ventricular (rv) lead exhibited myopotential noise.This noise was reproduced with body movement testing.Technical services (ts) analyzed device episode data and found an episode where there was oversensing of the noise which resulted in one burst of anti-tachycardia pacing (atp) being delivered.An insulation breach was suspected.It was noted that the patient was scheduled for a defibrillation threshold (dft) test because it had not been done during new implant and that increasing the programmed sensitivity would be done.However, it was decided to explant this lead and replace with a new rv lead.No additional adverse patient effects were reported.As of today, this product has not been returned to boston scientific for analysis.Ck.
 
Event Description
It was reported that this right ventricular (rv) lead exhibited myopotential noise.This noise was reproduced with body movement testing.Technical services (ts) analyzed device episode data and found an episode where there was oversensing of the noise which resulted in one burst of anti-tachycardia pacing (atp) being delivered.An insulation breach was suspected.It was noted that the patient was scheduled for a defibrillation threshold (dft) test because it had not been done during new implant and that increasing the programmed sensitivity would be done.However, it was decided to explant this lead and replace with a new rv lead.No additional adverse patient effects were reported.As of today, this product has not been returned to boston scientific for analysis.According to additional information, this lead exhibited low impedance measurements prior to extraction.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDOTAK RELIANCE SG
Type of Device
IMPLANTABLE LEAD
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
road 698, lot no. 12
dorado PR 00646 -260
*   00646-2602
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key18978458
MDR Text Key338596506
Report Number2124215-2024-18127
Device Sequence Number1
Product Code NVY
UDI-Device Identifier00802526531255
UDI-Public00802526531255
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P910073/S077
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/28/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/26/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date07/12/2015
Device Model Number0293
Device Catalogue Number0293
Device Lot Number115025
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/18/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/12/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age47 YR
Patient SexFemale
-
-